• Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Podcast
  • Awards
  • Join
  • Sign in
Skip to content
Cannabiz

Cannabiz

The Business of Cannabis

  • Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Podcast
  • Awards
  • Join
  • Sign in
Home » Dr Paul Gavin » Page 2

Tag: Dr Paul Gavin

Avecho doses first patient in phase III sleep trial

Avatar photo by Martin Lane May 16, 2024July 16, 2024

Avecho has dosed the first patient in a phase III clinical trial testing an oral CBD […]

Recruitment for Avecho’s sleep trial gets underway

Avatar photo by Martin Lane March 26, 2024July 16, 2024

Avecho gets go ahead for Phase III sleep trial

Avatar photo by Martin Lane March 7, 2024July 16, 2024

Avecho raises another A$6m to fund trial as firm enters ‘defining chapter’

by Steve Jones August 28, 2023April 30, 2024

Avecho completes development of fast-onset CBD gummy product

Avatar photo by Martin Lane June 14, 2023April 30, 2024

Company news: Asterion; Ecofibre; Avecho; Epsilon Healthcare; Creso Pharma; Cann Global

Avatar photo by Martin Lane and Steve Jones May 18, 2023April 30, 2024

Avecho turns to new investors to raise funds for CBD clinical trial

by Steve Jones May 9, 2023April 30, 2024

Avecho plots A$11m capital raise to underpin CBD clinical trial

by Steve Jones April 3, 2023April 30, 2024

Lambert researchers to study Avecho CBD soft gel for novel indications

by Steve Jones February 22, 2023April 30, 2024

Company news: Avecho; Levin Health; Cannatrek; Releaf Group; Bod Science

Avatar photo by Martin Lane and Steve Jones December 22, 2022April 29, 2024

Posts pagination

Newer posts 1 2 3 4 Older posts

My Account

Sign in

Category

  • Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Podcast
  • Awards

About

  • About/contact us
  • Join
  • Sign in
  • Privacy Policy
  • Website Terms & Conditions
  • Membership Terms & Conditions
  • Submit a Guest Post
  • About cannabis
  • Editorial policy
Cannabiz
  • Linkedin
  • Instagram
© 2026 Cannabiz.